Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes (Liratime)

This study has been completed.
Novo Nordisk A/S
Information provided by (Responsible Party):
Peter Rossing, Steno Diabetes Center
ClinicalTrials.gov Identifier:
First received: December 12, 2011
Last updated: January 30, 2015
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2014
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
No publications provided by Steno Diabetes Center

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):